These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 2871581)
1. 3,4-Methylenedioxymethamphetamine (MDMA): stereoselective interactions at brain 5-HT1 and 5-HT2 receptors. Lyon RA; Glennon RA; Titeler M Psychopharmacology (Berl); 1986; 88(4):525-6. PubMed ID: 2871581 [TBL] [Abstract][Full Text] [Related]
2. Influence of inducers and inhibitors on the metabolism in vitro and neurochemical effects in vivo of MDMA. Gollamudi R; Ali SF; Lipe G; Newport G; Webb P; Lopez M; Leakey JE; Kolta M; Slikker W Neurotoxicology; 1989; 10(3):455-66. PubMed ID: 2576302 [TBL] [Abstract][Full Text] [Related]
3. 3,4-Methylenedioxymethamphetamine and 3,4-methylenedioxyamphetamine destroy serotonin terminals in rat brain: quantification of neurodegeneration by measurement of [3H]paroxetine-labeled serotonin uptake sites. Battaglia G; Yeh SY; O'Hearn E; Molliver ME; Kuhar MJ; De Souza EB J Pharmacol Exp Ther; 1987 Sep; 242(3):911-6. PubMed ID: 2443644 [TBL] [Abstract][Full Text] [Related]
4. Pharmacologic profile of amphetamine derivatives at various brain recognition sites: selective effects on serotonergic systems. Battaglia G; De Souza EB NIDA Res Monogr; 1989; 94():240-58. PubMed ID: 2514364 [TBL] [Abstract][Full Text] [Related]
5. Hallucinogenic drug interactions at human brain 5-HT2 receptors: implications for treating LSD-induced hallucinogenesis. Sadzot B; Baraban JM; Glennon RA; Lyon RA; Leonhardt S; Jan CR; Titeler M Psychopharmacology (Berl); 1989; 98(4):495-9. PubMed ID: 2505289 [TBL] [Abstract][Full Text] [Related]
6. Stereochemical effects of 3,4-methylenedioxymethamphetamine (MDMA) and related amphetamine derivatives on inhibition of uptake of [3H]monoamines into synaptosomes from different regions of rat brain. Steele TD; Nichols DE; Yim GK Biochem Pharmacol; 1987 Jul; 36(14):2297-303. PubMed ID: 2886126 [TBL] [Abstract][Full Text] [Related]
7. 5-HT1 and 5-HT2 binding properties of derivatives of the hallucinogen 1-(2,5-dimethoxyphenyl)-2-aminopropane (2,5-DMA). Shannon M; Battaglia G; Glennon RA; Titeler M Eur J Pharmacol; 1984 Jun; 102(1):23-9. PubMed ID: 6479216 [TBL] [Abstract][Full Text] [Related]
8. Pharmacologic profile of MDMA (3,4-methylenedioxymethamphetamine) at various brain recognition sites. Battaglia G; Brooks BP; Kulsakdinun C; De Souza EB Eur J Pharmacol; 1988 Apr; 149(1-2):159-63. PubMed ID: 2899513 [TBL] [Abstract][Full Text] [Related]
9. Selectivity of serotonergic drugs for multiple brain serotonin receptors. Role of [3H]-4-bromo-2,5-dimethoxyphenylisopropylamine ([3H]DOB), a 5-HT2 agonist radioligand. Titeler M; Lyon RA; Davis KH; Glennon RA Biochem Pharmacol; 1987 Oct; 36(19):3265-71. PubMed ID: 3663239 [TBL] [Abstract][Full Text] [Related]
10. Stereochemistry of the metabolism of MDMA to MDA. Fitzgerald RL; Blanke RV; Rosecrans JA; Glennon RA Life Sci; 1989; 45(4):295-301. PubMed ID: 2569654 [TBL] [Abstract][Full Text] [Related]
11. Behavioral effects of (+-) 3,4-methylenedioxyamphetamine (MDA) and (+-) 3,4-methylenedioxymethamphetamine (MDMA) in the pigeon: interactions with noradrenergic and serotonergic systems. Nader MA; Hoffmann SM; Barrett JE Psychopharmacology (Berl); 1989; 98(2):183-8. PubMed ID: 2569215 [TBL] [Abstract][Full Text] [Related]
12. Ring-substituted amphetamine interactions with neurotransmitter receptor binding sites in human cortex. Pierce PA; Peroutka SJ Neurosci Lett; 1988 Dec; 95(1-3):208-12. PubMed ID: 2906416 [TBL] [Abstract][Full Text] [Related]
13. Serotonin 5-HT1-like receptors mediate hyperactivity in rats induced by 3,4-methylenedioxymethamphetamine. Callaway CW; Rempel N; Peng RY; Geyer MA Neuropsychopharmacology; 1992 Sep; 7(2):113-27. PubMed ID: 1358088 [TBL] [Abstract][Full Text] [Related]
14. Effect of 3,4-methylenedioxymethamphetamine on [3H]paroxetine binding in the frontal cortex and blood platelets of rats. Nash JF; Arora RC; Schreiber MA; Meltzer HY Biochem Pharmacol; 1991 Jan; 41(1):79-84. PubMed ID: 1702633 [TBL] [Abstract][Full Text] [Related]
15. 3H-DOB (4-bromo-2,5-dimethoxyphenylisopropylamine) labels a guanyl nucleotide-sensitive state of cortical 5-HT2 receptors. Lyon RA; Davis KH; Titeler M Mol Pharmacol; 1987 Feb; 31(2):194-9. PubMed ID: 3543649 [TBL] [Abstract][Full Text] [Related]
16. (+/-)3,4-Methylenedioxymethamphetamine (MDMA) produces long-term reductions in brain 5-hydroxytryptamine in rats. Mokler DJ; Robinson SE; Rosecrans JA Eur J Pharmacol; 1987 Jun; 138(2):265-8. PubMed ID: 2887440 [TBL] [Abstract][Full Text] [Related]
17. Intrasynaptosomal sequestration of [3H]amphetamine and [3H]methylenedioxyamphetamine: characterization suggests the presence of a factor responsible for maintaining sequestration. Zaczek R; Culp S; De Souza EB J Neurochem; 1990 Jan; 54(1):195-204. PubMed ID: 1967142 [TBL] [Abstract][Full Text] [Related]
18. Spectral and inhibitory interactions of (+/-)-3,4-methylenedioxyamphetamine (MDA) and (+/-)-3,4-methylenedioxymethamphetamine (MDMA) with rat hepatic microsomes. Brady JF; Di Stefano EW; Cho AK Life Sci; 1986 Oct; 39(16):1457-64. PubMed ID: 2877380 [TBL] [Abstract][Full Text] [Related]